Khadar Abdi Email

Senior Scientist . Tellus Therapeutics

Current Roles

Employees:
13
Revenue:
$1M
About
Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. Tellus' lead candidate, TT-20, induces regeneration of myelin-producing oligodendrocytes, reverses white matter injury in an animal models of perinatal brain injury and multiple sclerosis and is pursuing a novel regulatory path to evaluate safety and efficacy in newborns with brain injury.
Tellus Therapeutics Address
517 Summit Trail Drive, Research Triangle Par
Hillsborough, NC
Tellus Therapeutics Email